Mosaic’s becoming

2023-09-11T16:06:43+01:0012 September 2023|

The Sanger Institute is committed to innovative science at scale, but we need partners and investors to transfer this science into the clinic. Mariya Chhatriwala, Business Development Manager, gives us her insights on how the Sanger Institute’s fifth spin-out company came to be.

Accidental Entrepreneur

2023-05-18T10:09:10+01:0023 March 2023|

In this third part of our innovator blog series, we spoke to Matt Hurles, Head of the Human Genetics programme and incoming Director of the Wellcome Sanger Institute. Matt defines himself as an accidental entrepreneur, even though he spearheads a number of innovative initiatives that showcase his motivation to ultimately bring benefits to patients.

A passion for problem solving

2023-02-23T14:02:51+00:009 February 2023|

As part of our innovator blog series, we spoke to Qianxin Wu who works jointly in our Cellular Genetics programme and our Cellular and Gene Editing R&D team. Qianxin is at the forefront of innovation, working on CRISPR, genome editing and single-cell technologies.

Spinning out the science

2021-12-05T10:22:05+00:002 December 2021|

Much of our research has the potential to positively impact people's lives around the world. And who better to deliver this than the scientists themselves?